:

Homeland Security

Cleveland BioLabs Completes Manufacturing Process for Radiation Drug

DDN

Wednesday, October 31st, 2007

SHARE:

Cleveland BioLabs [CBLI] has completed the technology transfer to its manufacturing partner for Protectan CBLB502, which the company has developed for medical radiation countermeasures to treat gastrointestinal effects of acute radiation syndrome. Production of the first Good Manufacturing Practices compliant batch of Protectan was also completed ahead of schedule. Cleveland BioLabs submitted Protectan in response to a Defense Department Request for Proposals. A contract would provide funding for development of the countermeasure through approval by the Food and Drug Administration,…

Budget

Hegseth Pushes For Reconciliation With At Least $350 Billion For Defense ‘Regardless’ Of Midterms Outcome

Defense Secretary Pete Hegseth said Wednesday the Trump administration plans to continue its push for at least $350 billion in defense funds via the reconciliation process “regardless of what happens […]

Congress

Bipartisan Push in Senate to Hasten Export of 155 mm, GMLRS, HIMARS for Ukraine

A small, bipartisan group of senators is backing the Fast Tracking European Investment in Ukraine’s Defense Act, S. 5175, to hasten the export of allied buys of U.S. munitions for […]

Congress

Rep. Himes Signals Increased Contractor Oversight, if Democrats Win House

Rep. Jim Himes (D-Conn.), the ranking member of the House Permanent Select Committee on Intelligence, plans to increase the committee’s contractor oversight if the Democrats win control of the House […]

Congress

CBO Estimates Loss of One-Half to Two-Thirds of U.S. Missile Interceptors Since June Last Year

A new Congressional Budget Office report estimates the cost of the Iran war through Aug. 1 as $38 billion and says that the U.S. has likely depleted between one-half and […]